NCT03909646 2025-05-06
BOWTIE
Maastricht University Medical Center
Phase 4 Completed
Clinical Trials
10 trialsNCT05522036 2023-10-18
Dermaris-35
Centre Dermatologique du Roy
Phase NA Completed
NCT02367547 2019-03-28
Superficial Basal Cell Cancer's Photodynamic Therapy: Comparing Three Photosensitizers: HAL and BF-200 ALA Versus MAL
Joint Authority for Päijät-Häme Social and Health Care
Phase 1/2 Unknown
NCT03012009 2018-01-25
Laser Assisted Drug Delivery in the Treatment of Superficial Non Melanoma Skin Cancer: a Randomized Controlled Trial
University Hospital, Ghent
Phase NA Completed
NCT01538901 2017-09-12
AKtransplant
Medical University of Vienna
Phase 4 Terminated
NCT03013647 2017-01-06
Daylight Photodynamic Therapy for Actinic Keratosis and Skin Field Cancerization
University of Sao Paulo General Hospital
Phase NA Unknown
NCT02149342 2016-07-11
Daylight-mediated Photodynamic Therapy of Actinic Keratoses:Comparing 0.2%HAL With 16%MAL
Joint Authority for Päijät-Häme Social and Health Care
Phase 1/2 Completed
NCT01491711 2014-01-31
Superficial Basal Cell Carcinoma Treatment With Topical Photodynamic Therapy With Fractionated 5-aminolevulinic Acid 20% Versus Two Stage Methylaminolevulinate
Maastricht University Medical Center
Phase 4 Unknown
NCT00926952 2011-09-09
Short Incubation Methylaminolevulinate Photodynamic Therapy Without Occlusion
Innovaderm Research Inc.
Phase 3 Completed
NCT00711178 2010-11-02
A Randomized Multicenter Study of Daylight Mediated Photodynamic Therapy (PDT)
Bispebjerg Hospital
Phase NA Completed